Your browser doesn't support javascript.
loading
Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line.
de Jong, Yvonne; van Maldegem, Annemiek M; Marino-Enriquez, Adrian; de Jong, Danielle; Suijker, Johnny; Briaire-de Bruijn, Inge H; Kruisselbrink, Alwine B; Cleton-Jansen, Anne-Marie; Szuhai, Karoly; Gelderblom, Hans; Fletcher, Jonathan A; Bovée, Judith V M G.
Afiliação
  • de Jong Y; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • van Maldegem AM; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Marino-Enriquez A; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • de Jong D; Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • Suijker J; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Briaire-de Bruijn IH; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Kruisselbrink AB; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Cleton-Jansen AM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Szuhai K; Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands.
  • Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Fletcher JA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Bovée JV; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Lab Invest ; 96(10): 1128-37, 2016 10.
Article em En | MEDLINE | ID: mdl-27617402
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Condrossarcoma Mesenquimal / Resistencia a Medicamentos Antineoplásicos / Proteínas Proto-Oncogênicas c-bcl-2 / Linhagem Celular Tumoral Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Condrossarcoma Mesenquimal / Resistencia a Medicamentos Antineoplásicos / Proteínas Proto-Oncogênicas c-bcl-2 / Linhagem Celular Tumoral Idioma: En Ano de publicação: 2016 Tipo de documento: Article